311 related articles for article (PubMed ID: 33139318)
1. Therapeutic Effect of Neuraminidase-1-Selective Inhibition in Mouse Models of Bleomycin-Induced Pulmonary Inflammation and Fibrosis.
Luzina IG; Lillehoj EP; Lockatell V; Hyun SW; Lugkey KN; Imamura A; Ishida H; Cairo CW; Atamas SP; Goldblum SE
J Pharmacol Exp Ther; 2021 Jan; 376(1):136-146. PubMed ID: 33139318
[TBL] [Abstract][Full Text] [Related]
2. The NEU1-selective sialidase inhibitor, C9-butyl-amide-DANA, blocks sialidase activity and NEU1-mediated bioactivities in human lung in vitro and murine lung in vivo.
Hyun SW; Liu A; Liu Z; Cross AS; Verceles AC; Magesh S; Kommagalla Y; Kona C; Ando H; Luzina IG; Atamas SP; Piepenbrink KH; Sundberg EJ; Guang W; Ishida H; Lillehoj EP; Goldblum SE
Glycobiology; 2016 Aug; 26(8):834-49. PubMed ID: 27226251
[TBL] [Abstract][Full Text] [Related]
3. Selective Inhibitors of Human Neuraminidase 1 (NEU1).
Guo T; Héon-Roberts R; Zou C; Zheng R; Pshezhetsky AV; Cairo CW
J Med Chem; 2018 Dec; 61(24):11261-11279. PubMed ID: 30457869
[TBL] [Abstract][Full Text] [Related]
4. Identification of selective inhibitors for human neuraminidase isoenzymes using C4,C7-modified 2-deoxy-2,3-didehydro-N-acetylneuraminic acid (DANA) analogues.
Zhang Y; Albohy A; Zou Y; Smutova V; Pshezhetsky AV; Cairo CW
J Med Chem; 2013 Apr; 56(7):2948-58. PubMed ID: 23530623
[TBL] [Abstract][Full Text] [Related]
5. Elevated expression of NEU1 sialidase in idiopathic pulmonary fibrosis provokes pulmonary collagen deposition, lymphocytosis, and fibrosis.
Luzina IG; Lockatell V; Hyun SW; Kopach P; Kang PH; Noor Z; Liu A; Lillehoj EP; Lee C; Miranda-Ribera A; Todd NW; Goldblum SE; Atamas SP
Am J Physiol Lung Cell Mol Physiol; 2016 May; 310(10):L940-54. PubMed ID: 26993524
[TBL] [Abstract][Full Text] [Related]
6. Inhibiting Sialidase-Induced TGF-
Karhadkar TR; Meek TD; Gomer RH
J Pharmacol Exp Ther; 2021 Jan; 376(1):106-117. PubMed ID: 33144389
[TBL] [Abstract][Full Text] [Related]
7. NEU1 and NEU3 sialidase activity expressed in human lung microvascular endothelia: NEU1 restrains endothelial cell migration, whereas NEU3 does not.
Cross AS; Hyun SW; Miranda-Ribera A; Feng C; Liu A; Nguyen C; Zhang L; Luzina IG; Atamas SP; Twaddell WS; Guang W; Lillehoj EP; Puché AC; Huang W; Wang LX; Passaniti A; Goldblum SE
J Biol Chem; 2012 May; 287(19):15966-80. PubMed ID: 22403397
[TBL] [Abstract][Full Text] [Related]
8. Changes in lung sialidases in male and female mice after bleomycin aspiration.
Pilling D; Sahlberg K; Chen W; Gomer RH
Exp Lung Res; 2022; 48(9-10):291-304. PubMed ID: 36382835
[No Abstract] [Full Text] [Related]
9. The sialidase NEU3 promotes pulmonary fibrosis in mice.
Pilling D; Sahlberg K; Karhadkar TR; Chen W; Gomer RH
Respir Res; 2022 Aug; 23(1):215. PubMed ID: 35999554
[TBL] [Abstract][Full Text] [Related]
10. Selective Inhibitors of Human Neuraminidase 3.
Guo T; Dätwyler P; Demina E; Richards MR; Ge P; Zou C; Zheng R; Fougerat A; Pshezhetsky AV; Ernst B; Cairo CW
J Med Chem; 2018 Mar; 61(5):1990-2008. PubMed ID: 29425031
[TBL] [Abstract][Full Text] [Related]
11. The sialidase NEU1 directly interacts with the juxtamembranous segment of the cytoplasmic domain of mucin-1 to inhibit downstream PI3K-Akt signaling.
Hyun SW; Imamura A; Ishida H; Piepenbrink KH; Goldblum SE; Lillehoj EP
J Biol Chem; 2021 Nov; 297(5):101337. PubMed ID: 34688655
[TBL] [Abstract][Full Text] [Related]
12. Thymoquinone from nutraceutical black cumin oil activates Neu4 sialidase in live macrophage, dendritic, and normal and type I sialidosis human fibroblast cells via GPCR Galphai proteins and matrix metalloproteinase-9.
Finlay TM; Jayanth P; Amith SR; Gilmour A; Guzzo C; Gee K; Beyaert R; Szewczuk MR
Glycoconj J; 2010 Apr; 27(3):329-48. PubMed ID: 20213245
[TBL] [Abstract][Full Text] [Related]
13. Neuraminidase 1-mediated desialylation of the mucin 1 ectodomain releases a decoy receptor that protects against
Lillehoj EP; Guang W; Hyun SW; Liu A; Hegerle N; Simon R; Cross AS; Ishida H; Luzina IG; Atamas SP; Goldblum SE
J Biol Chem; 2019 Jan; 294(2):662-678. PubMed ID: 30429216
[No Abstract] [Full Text] [Related]
14. Design, synthesis, and biological evaluation of human sialidase inhibitors. Part 1: selective inhibitors of lysosomal sialidase (NEU1).
Magesh S; Moriya S; Suzuki T; Miyagi T; Ishida H; Kiso M
Bioorg Med Chem Lett; 2008 Jan; 18(2):532-7. PubMed ID: 18068975
[TBL] [Abstract][Full Text] [Related]
15. Attenuated pulmonary fibrosis in sialidase-3 knockout (
Karhadkar TR; Chen W; Gomer RH
Am J Physiol Lung Cell Mol Physiol; 2020 Jan; 318(1):L165-L179. PubMed ID: 31617733
[TBL] [Abstract][Full Text] [Related]
16. Molecular dynamics simulations of viral neuraminidase inhibitors with the human neuraminidase enzymes: Insights into isoenzyme selectivity.
Richards MR; Guo T; Hunter CD; Cairo CW
Bioorg Med Chem; 2018 Oct; 26(19):5349-5358. PubMed ID: 29903413
[TBL] [Abstract][Full Text] [Related]
17. Validation of the 2nd Generation Proteasome Inhibitor Oprozomib for Local Therapy of Pulmonary Fibrosis.
Semren N; Habel-Ungewitter NC; Fernandez IE; Königshoff M; Eickelberg O; Stöger T; Meiners S
PLoS One; 2015; 10(9):e0136188. PubMed ID: 26340365
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-37 Attenuates Bleomycin-Induced Pulmonary Inflammation and Fibrosis in Mice.
Li Y; Gao Q; Xu K; Peng X; Yuan X; Jiang W; Li M
Inflammation; 2018 Oct; 41(5):1772-1779. PubMed ID: 29956068
[TBL] [Abstract][Full Text] [Related]
19. Prevention and treatment of bleomycin-induced pulmonary fibrosis with the lactate dehydrogenase inhibitor gossypol.
Judge JL; Nagel DJ; Owens KM; Rackow A; Phipps RP; Sime PJ; Kottmann RM
PLoS One; 2018; 13(5):e0197936. PubMed ID: 29795645
[TBL] [Abstract][Full Text] [Related]
20. Sunitinib, a Small-Molecule Kinase Inhibitor, Attenuates Bleomycin-Induced Pulmonary Fibrosis in Mice.
Huang X; Wang W; Yuan H; Sun J; Li L; Wu X; Luo J; Gu Y
Tohoku J Exp Med; 2016 Aug; 239(4):251-61. PubMed ID: 27439438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
